改善患有CF的婴儿的生长
Megan E Gabel1,2, Rachel E Gaudio3, Ala K Shaikhkhalil4,5
1University of Rochester Medical Center, University of Rochester, Rochester, New York, USA.
Pediatric pulmonology
|August 6, 2024
概括
囊性纤维化 (CF) 婴儿从出生就面临生长挑战,影响健康结果. 早期营养支持和跨学科护理对于改善CF儿童的生长和生存至关重要.
科学领域:
- 儿童营养学 儿童营养学
- 胃肠病学 胃肠病学
- 肺部病理学 肺部病理学
背景情况:
- 囊性纤维化 (CF) 是一种遗传性疾病,导致慢性肺部和胃肠道问题.
- 营养不良和生长不良是CF的重要并发症,与不良的临床结果相关.
- 通过新生儿查进行早期诊断,可以迅速进行营养干预和临床管理.
研究的目的:
- 突出优化患有囊性纤维化诊断的婴儿生长的关键重要性.
- 强调在CF护理中管理婴儿成长的挑战和优先事项.
- 强调需要一个全面的,跨学科的方法来CF婴儿管理.
主要方法:
- 审查目前对患有CF的婴儿生长障碍的理解.
- 强调早期营养咨询和临床随访的作用.
- 强调需要综合护理,包括注册营养师和社会工作人员.
主要成果:
- 患有CF的婴儿通常会经历子宫内生长限制和降低出生体重.
- 在CF中改善婴儿生长明显与更好的临床结果和生存率有关.
- 尽管取得了进展,但在线增长,营养生物标志物和健康不平等方面仍然存在挑战.
结论:
- 优化生长是患有囊性纤维化的婴儿最关心的问题.
- 跨学科的团队方法对于解决CF婴儿复杂的营养和健康需求至关重要.
- 克服诸如健康的社会决定因素等障碍对全球CF社区至关重要.
相关概念视频
Cystic Fibrosis: Management
150
Cystic fibrosis (CF) is an autosomal recessive disorder that predominantly affects individuals of Northern European descent, occurring at a rate of 1 in 3500. It is caused by a genetic mutation in a gene on chromosome 7, most commonly the ΔF508 mutation, that codes for the cystic fibrosis transmembrane conductance regulator (CFTR) protein. This results in thicker mucus secretions and obstruction pathologies in multiple organs, including the lungs and sinuses.
Sinus disease and chronic...
Sinus disease and chronic...
150
Cystic Fibrosis: Pathogenesis
201
Cystic fibrosis (CF), an autosomal recessive disorder, significantly affects the function of exocrine glands. This genetically inherited disease is characterized by the production of thick and sticky mucus, which can severely affect various organs and systems in the body.
CF is primarily caused by a genetic mutation in a chromosome 7 gene coding for the cystic fibrosis transmembrane conductance regulator (CFTR) protein. The most common gene mutation leading to CF is the ΔF508 mutation,...
CF is primarily caused by a genetic mutation in a chromosome 7 gene coding for the cystic fibrosis transmembrane conductance regulator (CFTR) protein. The most common gene mutation leading to CF is the ΔF508 mutation,...
201
Acute Respiratory Failure-V
126
The treatment for acute respiratory failure varies based on factors like the underlying cause, overall health, and severity. A collaborative healthcare team is essential for early detection, often through arterial blood gas analysis. Identifying the cause is the primary goal, with treatment strategies adjusted for ventilation/perfusion (V/Q) mismatch, shunting, or diffusion impairment.
Ensure that patients are monitored continuously for their response to therapy, including changes in...
Ensure that patients are monitored continuously for their response to therapy, including changes in...
126


